{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T19:40:09Z","timestamp":1743363609264,"version":"3.40.3"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Shanghai University of Traditional Chinese Medicine Industrial Development Center's Medical and Elderly Care Innovation Project","award":["YYKC-2021-01-102"],"award-info":[{"award-number":["YYKC-2021-01-102"]}]},{"name":"Shanghai Traditional Chinese Medicine Critical and Emergency Care Platform Scientific Management Project","award":["ZYJZNLTS1-5"],"award-info":[{"award-number":["ZYJZNLTS1-5"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,7]]},"abstract":"<jats:p>This study assesses the causal effects of antihypertensive and lipid-lowering drugs on inflammatory cytokines using a Mendelian randomization (MR) approach. We conducted a drug-targeted MR analysis using data from large-scale genome-wide association studies and eQTL datasets. SNPs near drug target genes served as instrumental variables to investigate the impact of antihypertensive (angiotensin-converting enzyme inhibitors [ACEIs], ARBs) and lipid-lowering drugs (HMGCR inhibitors, proprotein convertase subtilisin\/Kexin type 9 [PCSK9] inhibitors, Niemann-Pick C1-like 1 inhibitors) on inflammatory cytokines. Sensitivity analyses, including leave-one-out and MR-Egger tests, were performed to confirm the robustness of the findings. ACEIs were associated with decreased levels of IL-1\u03b2, TNF-\u03b1, and CRP. ARBs did not show significant effects on inflammatory cytokines. HMGCR inhibitors significantly reduced MCP-1, MIP-1\u03b2, TNF-\u03b1, and IFN-\u03b3, while PCSK9 inhibitors were linked to reductions in IL-1\u03b2 and IL-6. Sensitivity analyses supported the reliability of these findings. The study demonstrated distinct anti-inflammatory effects of ACEIs, HMGCR inhibitors, and PCSK9 inhibitors. These findings support the potential use of these drugs to mitigate inflammation-related complications in patients with chronic conditions.<\/jats:p>","DOI":"10.1097\/md.0000000000041771","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T23:41:36Z","timestamp":1743205296000},"page":"e41771","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mendelian randomization-based observational cohort study on drug targets: Impact of antihypertensive and lipid-lowering therapies on inflammatory cytokines"],"prefix":"10.1097","volume":"104","author":[{"given":"Jiechen","family":"Xin","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaojun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9202-657X","authenticated-orcid":false,"given":"Longshu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250328","doi-asserted-by":"crossref","first-page":"103410","DOI":"10.1016\/j.autrev.2023.103410","article-title":"Immune-mediated inflammatory diseases: common and different pathogenic and clinical features.","volume":"22","author":"Monteleone","year":"2023","journal-title":"Autoimmun Rev"},{"key":"R2-20250328","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm.","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"R3-20250328","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The \u201ccytokine storm\u201d: molecular mechanisms and therapeutic prospects.","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol"},{"key":"R4-20250328","doi-asserted-by":"crossref","first-page":"e2108476","DOI":"10.1002\/adma.202108476","article-title":"Biomimetic immunosuppressive exosomes that inhibit cytokine storms contribute to the alleviation of sepsis.","volume":"34","author":"Li","year":"2022","journal-title":"Adv Mater"},{"key":"R5-20250328","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine storms: understanding COVID-19.","volume":"53","author":"Mangalmurti","year":"2020","journal-title":"Immunity"},{"key":"R6-20250328","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11136-021-02917-y","article-title":"Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic.","volume":"31","author":"Souliotis","year":"2022","journal-title":"Qual Life Res"},{"issue":"Pt A","key":"R7-20250328","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.","volume":"125","author":"Li","year":"2017","journal-title":"Pharmacol Res"},{"key":"R8-20250328","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41587-020-00796-1","article-title":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19.","volume":"39","author":"Trump","year":"2021","journal-title":"Nat Biotechnol"},{"key":"R9-20250328","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/07853890.2018.1498118","article-title":"Lipid lowering drugs and inflammatory changes: an impact on cardiovascular outcomes?","volume":"50","author":"Ruscica","year":"2018","journal-title":"Ann Med"},{"key":"R10-20250328","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.mayocp.2022.06.036","article-title":"Effect of the renin-angiotensin system inhibitors on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials.","volume":"97","author":"Awad","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"R11-20250328","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/ijms23031772","article-title":"Immunomodulatory activity of the most commonly used antihypertensive drugs-angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.","volume":"23","author":"Bryniarski","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R12-20250328","doi-asserted-by":"crossref","first-page":"e2004433","DOI":"10.1002\/advs.202004433","article-title":"Cytokines: from clinical significance to quantification.","volume":"8","author":"Liu","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"R13-20250328","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease.","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"R14-20250328","first-page":"127","article-title":"The influence of treatment with PCSK9 inhibitors and variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) genes on the corresponding inflammatory markers in patients with very high lipoprotein(a) levels.","volume":"9","author":"Levstek","year":"2022","journal-title":"J Cardiovasc Develop Dis"},{"key":"R15-20250328","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/bcp.12905","article-title":"Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: a meta-analysis of 16 randomized controlled treatment arms.","volume":"81","author":"Sahebkar","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"R16-20250328","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cvr\/cvae034","article-title":"Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials.","volume":"120","author":"Xie","year":"2024","journal-title":"Cardiovasc Res"},{"key":"R17-20250328","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation.","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat Commun"},{"key":"R18-20250328","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","article-title":"Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.","volume":"2","author":"Folkersen","year":"2020","journal-title":"Nat Metab"},{"key":"R19-20250328","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00125-021-05645-7","article-title":"Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.","volume":"65","author":"Zhao","year":"2022","journal-title":"Diabetologia"},{"key":"R20-20250328","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41591-021-01310-z","article-title":"Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.","volume":"27","author":"Gaziano","year":"2021","journal-title":"Nat Med"},{"key":"R21-20250328","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41588-024-01714-w","article-title":"Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits.","volume":"56","author":"Keaton","year":"2024","journal-title":"Nat Genet"},{"key":"R22-20250328","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels.","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"key":"R24-20250328","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues.","volume":"369","year":"2020","journal-title":"Science"},{"key":"R25-20250328","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","article-title":"Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors.","volume":"100","author":"Ahola-Olli","year":"2017","journal-title":"Am J Hum Genet"},{"year":"2024","article-title":"CARDIoGRAMplusC4D Consortium.","key":"R26-20250328"},{"key":"R27-20250328","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/v14010065","article-title":"Inhibitory effect of IL-1\u03b2 on HBV and HDV replication and HBs antigen-dependent modulation of its secretion by macrophages.","volume":"14","author":"Delphin","year":"2021","journal-title":"Viruses"},{"key":"R28-20250328","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1681\/ASN.2011030287","article-title":"Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.","volume":"23","author":"Gamboa","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R29-20250328","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jaci.2010.11.005","article-title":"TNF-like weak inducer of apoptosis (TWEAK) and TNF-\u03b1 cooperate in the induction of keratinocyte apoptosis.","volume":"127","author":"Zimmermann","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R30-20250328","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1161\/HYPERTENSIONAHA.122.19312","article-title":"Effects of ramipril on biomarkers of endothelial dysfunction and inflammation in hypertensive children on maintenance hemodialysis: the SEARCH randomized placebo-controlled trial.","volume":"79","author":"Ateya","year":"2022","journal-title":"Hypertension"},{"key":"R31-20250328","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2005.03.031","article-title":"Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein.","volume":"184","author":"Devaraj","year":"2006","journal-title":"Atherosclerosis"},{"key":"R32-20250328","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S0828-282X(09)70508-2","article-title":"Effect of angiotensin-converting enzyme inhibition on C-reactive protein levels: the ramipril C-reactive pRotein randomized evaluation (4R) trial results.","volume":"25","author":"Verma","year":"2009","journal-title":"Can J Cardiol"},{"key":"R33-20250328","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.metabol.2005.04.008","article-title":"The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia.","volume":"54","author":"Takebayashi","year":"2005","journal-title":"Metabolism"},{"key":"R34-20250328","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/rheumatology\/ken466","article-title":"Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes.","volume":"48","author":"Montecucco","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R35-20250328","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejheart.2005.10.011","article-title":"Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE.","volume":"8","author":"Kovacs","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"R36-20250328","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fnagi.2016.00206","article-title":"Combined treatment with amlodipine and atorvastatin calcium reduces circulating levels of intercellular adhesion molecule-1 and tumor necrosis factor-\u03b1 in hypertensive patients with prediabetes.","volume":"8","author":"Huang","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"R37-20250328","doi-asserted-by":"crossref","first-page":"11717","DOI":"10.1038\/s41598-019-48282-2","article-title":"Atorvastatin increases the production of proinflammatory cytokines and decreases the survival of Escherichia coli-infected mice.","volume":"9","author":"Hussein","year":"2019","journal-title":"Sci Rep"},{"key":"R38-20250328","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/cen.12113","article-title":"Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low\u2010dose atorvastatin treatment: evidence from a randomized controlled trial.","volume":"79","author":"Loughrey","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R39-20250328","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3892\/ijmm.2012.1072","article-title":"PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-\u03baB activation in THP-1-derived macrophages.","volume":"30","author":"Tang","year":"2012","journal-title":"Int J Mol Med"},{"key":"R40-20250328","first-page":"2944","article-title":"Comparison of the efficacy of PCSK9 inhibitors and statins on dyslipidemia in patients with type 2 diabetes.","volume":"102","author":"Wang","year":"2022","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R41-20250328","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jacc.2022.10.030","article-title":"PCSK9 inhibition during the inflammatory stage of SARS-CoV-2 infection.","volume":"81","author":"Navarese","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R42-20250328","doi-asserted-by":"crossref","first-page":"763516","DOI":"10.3389\/fcvm.2022.763516","article-title":"Proprotein convertase Subtilisin\/Kexin Type 9 and inflammation: an updated review.","volume":"9","author":"Wu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R43-20250328","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R44-20250328","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3945\/ajcn.115.118216","article-title":"Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies.","volume":"103","author":"Haycock","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"R45-20250328","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/ije\/dyz155","article-title":"Repurposing antihypertensive drugs for the prevention of Alzheimer\u2019s disease: a Mendelian randomization study.","volume":"49","author":"Walker","year":"2020","journal-title":"Int J Epidemiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041771","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T19:19:30Z","timestamp":1743362370000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041771","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}